CLINICAL_TRIALS
trial_result
· 2014-05-22
Clinical Trial Update: Intensified Post Remission Therapy Containing PEG-Asparaginase [Phase 2]
Summary
Phase 2 trial update evaluating intensified post-remission therapy containing pegaspargase for acute lymphoblastic leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Southern California | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED